Orna Therapeutics Unveils Novel In Vivo Gene Editing Data Highlighting Engineering and Delivery Approach at the 31st Annual European Society of Gene & Cell Therapy Congress
Hand-out
Press Releases
Orna Therapeutics  
October 22, 2024

Orna Therapeutics Unveils Novel In Vivo Gene Editing Data Highlighting Engineering and Delivery Approach at the 31st Annual European Society of Gene & Cell Therapy Congress

--Lead type V editor program in SCD demonstrates industry leading delivery and repeat dosing with a passive LNP--

avatar profile Olean Times Herald

Olean Times Herald


Local & Social